ライフサイエンスコーパス: isoflavone

1 avones, 2 flavonols, 2 phenylethanoids and 1 isoflavone).

2 o anticancer effects of genistein, a soybean isoflavone.

3 ium oxide by specific retention of 5-hydroxy isoflavone.

4 oporous resin and aluminium oxide to isolate isoflavone.

5 were tested while assaying soy glycosilated isoflavones.

6 as evaluated as potential tool to purify soy isoflavones.

7 ed the extractability of total phenolics and isoflavones.

8 thodology to extract, concentrate and purify isoflavones.

9 urce of macronutrients and phytochemicals as isoflavones.

10 cium, vitamin D, protein, potassium, and soy isoflavones.

11 ly because they are uniquely rich sources of isoflavones.

12 perature hardly affected the total amount of isoflavones.

13 ols and flavonols with soybean having mainly isoflavones.

14 entified as one of the up-regulated genes by isoflavones.

15 were screened as putative sources of dietary isoflavones.

16 ure of 30 degrees C was deleterious to grape isoflavones.

17 nd influences of dietary components, such as isoflavones.

18 plement based on soy germ containing 55.24mg isoflavones.

19 2DM treated with soy, either with or without isoflavones.

20 roved in EPs at 24 h (cfPWV change from 0 h: isoflavone, -0.2 +/- 0.2 m/s; placebo, 0.6 +/- 0.2 m/s;

21 3.48 ppb [95% CI, -5.99 to -0.97 ppb] vs soy isoflavones, 1.39 ppb [95% CI, -1.73 to 4.51 ppb]) did n

22 ither high-normal (73 mg/d) or low (10 mg/d) isoflavones, 2) soy foods with or without a prebiotic to

23 st (placebo, 1.98 [95% CI, 1.42-2.54] vs soy isoflavones, 2.20 [95% CI, 1.53-2.87]; positive values i

24 ntrol (placebo, 3.3 [95% CI, 2.7-4.1] vs soy isoflavones, 3.0 [95% CI, 2.4-3.7]), and changes in exha

25 the sum of individuals and 20% by F-C assay; isoflavones 36% and constituents with antioxidant activi

26 of soy isoflavone capsules (80 mg/d of total isoflavones, 51 mg/d aglucon units) on serum and tissue

27 reviously unreported compounds including two isoflavones 7,5'-dihydroxy-6,3'-dimethoxy-isoflavone-7-O

28 noside (4) and 7,5'-dihydroxy-6,3'-dimethoxy-isoflavone-7-O-(7,8-dihydro-p-hydroxycinnamoyl)-bet a-d-

29 wo isoflavones 7,5'-dihydroxy-6,3'-dimethoxy-isoflavone-7-O-beta-d-glucopyranoside (4) and 7,5'-dihyd

30 o furanonaphtoquinones, a furanochromone, an isoflavone, a stilbene and an iridoid).

31 excretion of glycitein compared to other soy isoflavones after a unique intake of food supplement bas

32 mg flavan-3-ols (90 mg epicatechin) + 100 mg isoflavones (aglycone equivalents)/d] or matched placebo

33 ection for the simultaneous determination of isoflavone aglycones (daidzein, glycitein and genistein)

34 sed a novel red clover extract (RCE) rich in isoflavone aglycones and probiotics to concomitantly pro

35 d type, and 4- and 7-fold increases of total isoflavone aglycones in Hefeng25 and Sfera, respectively

36 When isolating studies that provide isoflavone aglycones in their treatment arm, the average

37 Maximum conversion of beta-glucosides into isoflavone aglycones involved soaking the soybeans at 5

38 Isoflavone aglycones show higher bioavailability than th

39 ffects against bone loss may be enhanced for isoflavone aglycones.

40 alcitriol (25 mug/d) given either RCE (60 mg isoflavone aglycones/d and probiotics) or a masked place

41 olecules (glucose, sucrose, and pinitol) and isoflavone aglycons were increased but the isoflavones g

42 Soy isoflavones, although not as potent as risedronate, are

43 he objective was to examine whether combined isoflavone and flavan-3-ol intake alters vascular functi

44 After the 8-wk isoflavone and placebo period, whole-genome arrays were

45 ine the beneficial effects of a bioavailable isoflavone and probiotic treatment against postmenopausa

46 This study aimed to evaluate the isoflavone and total phenolic contents in kefir-fermente

47 After the fermentation and storage, the isoflavone and total phenolic contents were quantified b

48 meters (NIRS) and analyzed by HPLC for total isoflavone and total saponin composition, as well as tot

49 rations of glycosylated, malonyl, and acetyl isoflavones and a corresponding increase in the concentr

50 evaluate changes in the phenolic compounds, isoflavones and antioxidant activity of soymilk followin

51 ein, formononetin, naringenin, equol, sum of isoflavones and coumestrol, than CNV and FRG milk.

52 However, clinical research shows that isoflavones and estrogen exert differing effects on a va

53 Isoflavones and isoflavanones were mainly found in elici

54 ies on its content in phytoestrogens such as isoflavones and lignans.

55 We examined how soy isoflavones and metabolites impact natural killer (NK) c

56 rmented soymilk is a good source of aglycone isoflavones and phenolics, since the content of these su

57 beta-Glycosylated isoflavones and soyasaponin B-I were the most abundant c

58 ability, the potential biological effects of isoflavones and soyasaponins in infants should not be ov

59 e present study we determine the contents of isoflavones and soyasaponins in seven soy-based infant f

60 The mean contents of isoflavones and soyasaponins were 65.9mg/kg and 55.0mg/1

61 f the contents of different forms of soybean isoflavones and the effect of germination time on these

62 ole soybean flour (WSF) on the conversion of isoflavones and the inactivation of trypsin inhibitors.

63 e storage process did not alter the aglycone isoflavones and total phenolic contents.

64 Eleven isoflavones and two pterocarpan phytoalexins forms were

65 Applications to a natural flavone, isoflavone, and quinolone are shown.

66 ls such as retinoids, botanicals such as soy isoflavones, and even moisturizers and sunscreen.

67 soybeans had significantly higher TPC, total isoflavones, and peroxyl, hydroxyl, and ABTS(+) radical

68 Isoflavones are an important defence against pathogens i

69 Isoflavones are classified as both phytoestrogens and se

70 Soy-protein and isoflavones are dissociated by water rinsing and prolong

71 Isoflavones are plant-derived chemicals that are potenti

72 e and femoral neck for all studies providing isoflavones as aglycones.Twenty-six RCTs (n = 2652) were

73 pidemiological studies implicate dietary soy isoflavones as breast cancer preventives, especially due

74 he lentil samples with a standard mixture of isoflavones at three levels of fortification (5, 25 and

75 nd does not prenylate flavanone, flavone, or isoflavone backbones, even though it shares several comm

76 able intestinal bacterial profile to enhance isoflavone bioavailability.

77 From a panel of phytoestrogen isoflavones, biochanin A (BCA) was identified as the mos

78 The aim of the present study was to analyse isoflavone biosynthesis in wild and cultivated soybeans

79 le aglycon appears to be the least extracted isoflavone by pressurized water.

80 The metabolism of isoflavones by bacteria plays a key role in their biotra

81 The mean estimated intake of isoflavones by infants fed soy-based formulas was 0.8mg/

82 It was demonstrated that this isoflavone can cross the blood-brain barrier, making it

83 ontrolled trial to examine the effect of soy isoflavone capsules (80 mg/d of total isoflavones, 51 mg

84 One pool was rich in chain prenylated isoflavones (cIsf), one in chain prenylated stilbenoids

85 tive of this study is thus to identify a soy isoflavone combination with lower levels of daidzein and

86 For treatment with soy isoflavone combination, genistein was always better take

87 anipulation of beta-glycosidase activity and isoflavone composition can be used to modulate aglycone

88 e, rapid, nondestructive method to determine isoflavone composition in ground soybeans.

89 (SIM) or almonds, and examined the impact of isoflavone composition in mediating conversion to aglyco

90 Useful isoflavone composition predictions for large numbers of

91 The isoflavone compounds activated the ISG54 promoter, media

92 ase reporter assay, we identified a class of isoflavone compounds that act as specific agonists of in

93 a new analytical method for determining five isoflavone compounds, three of which are aglycons, namel

94 ompounds and eleven bound phenolics in a soy isoflavone concentrate.

95 RCE significantly elevated the plasma isoflavone concentration (P < 0.05), the urinary 2-hydro

96 We describe the effects of soy isoflavone consumption on prostate specific antigen (PSA

97 erences in soy isoflavone intake by country, isoflavone consumption was inversely associated with rec

98 14% by Folin-Ciocalteu [F-C] method), total isoflavone content (22%) and total antioxidant activity

99 Total isoflavone content in commercial soy milk samples (n=8)

100 s, which is possibly related to the specific isoflavone content or the variable equol-producing capac

101 The determination of isoflavone content was performed by high-performance liq

102 All fermentation parameters affected the isoflavone content when fermented by Monascus purpureus,

103 The correlation of total isoflavone content with the phylogeny of this set of pla

104 The function responses were isoflavone content, total phenolic content (TPC), and an

105 central Italy and pulses for determining the isoflavone content, which was found to range from 1.1 to

106 used to develop optimized models to predict isoflavone content.

107 tisus scoparius possessing the highest total isoflavones content (396 and 273 mg kg(-1), respectively

108 the effects of cooking and digestion on the isoflavone contents and bioactivities of the whole soy e

109 joint optimisation of the total phenolic and isoflavone contents as well as antioxidant activities: 0

110 sed and the extraction time on the extracted isoflavone contents from soybean.

111 vestigated for beta-glucosidase activity and isoflavone contents.

112 process parameters in obtaining the WSF with isoflavone conversions and reductions in trypsin inhibit

113 Compared to purified single isoflavones, cooked and digested soy were more effective

114 ms of isoflavone, then individual species of isoflavone could be isolated using aluminium oxide by sp

115 th supplements provided approximately 100 mg isoflavones/d (aglycone equivalents).

116 e soy intervention delivered 105.23 mg total isoflavones/d as genistein, daidzein, and glycitein in t

117 ventions that ranged from 52 to 220 mg total isoflavones/d increased bone calcium retention between 3

118 the pooled analysis, consumption of >/=10 mg isoflavones/d was associated with a nonsignificant reduc

119 stdiagnosis soy food consumption of >/=10 mg isoflavones/d was associated with a nonsignificant reduc

120 reported that equol, a metabolite of the soy isoflavone daidzein, may advance breast cancer potential

121 equol, a microbial-derived metabolite of the isoflavone daidzein, which is produced in the large inte

122 The photochemical behaviors of the isoflavones daidzein, formononetin, biochanin A, geniste

123 very, we discovered that an FDA-approved soy isoflavone, daidzein, improved stroke-induced behavioral

124 and inulin amount (X3) on transformation of isoflavones (daidzin and daidzein) to equol in soymilk f

125 hod for the simultaneous quantification of 6 isoflavones (daidzin, genistin, daidzein, genistein, for

126 constant (K), time (tau(50)) in which 50% of isoflavone deglycosylation was reached, and time (tau(co

127 (tau(complete)) required to achieve complete isoflavone deglycosylation, were 0.16+/-0.02 min(-1), 4.

128 on of the malonyls-glucosides and glucosides isoflavone derivatives into glucosides or aglycons forms

129 e data suggest that short-term intake of soy isoflavones did not affect serum hormone levels, total c

130 the concern for consumers taking regular soy isoflavone dietary supplements.

131 rmine whether the acute vascular benefits of isoflavones differ according to EP phenotype and subsequ

132 The richest source of isoflavones, especially formononetin were sprouts cultiv

133 or 25 degrees C) to maximise the content of isoflavones, especially of high affinity for ERbeta.

134 olled intervention with a genistein-rich soy isoflavone extract (10mg/kg/day of genistein) followed b

135 samples obtained from cows that received the isoflavone extract-supplemented diet than from those tha

136 ture, contact time and solid liquid ratio on isoflavone extraction from soybean flour or Soybean Prot

137 s no significant difference (p>0.05) between isoflavone extraction in water and in 70% aqueous ethano

138 otein Isolate compared to soybean flour, the isoflavone extraction yield is 61%.

139 ne (total aglycone/total isoflavones) in SIM isoflavone extracts increased significantly in raw (35%)

140 p-nitrophenol-beta-d-glucopyranoside and SIM isoflavone extracts.

141 organic acids, and sugars) and 10 secondary (isoflavones, fatty acid methyl esters) metabolites.

142 s of phytochemicals, such as phenolic acids, isoflavones, flavones, flavonols and glucosinolates were

143 s were taken to be the contents of different isoflavone forms and the residual activity of trypsin in

144 During storage, there was a conversion of isoflavone forms to aglycones, being higher in heat-proc

145 red the content and profile of the different isoflavones forms.

146 een' extraction solvent for the isolation of isoflavones from okara, a by-product of soymilk producti

147 sed as a green alternative for separation of isoflavones from okara.

148 ch confirms a high separating efficiency for isoflavones from soybean.

149 little is known about the bioavailability of isoflavones from whole soy food and their bioactivities

150 containing recombinant LaPT1 prenylated the isoflavone genistein at the B-ring 3' position to produc

151 The isoflavone genistein on the contrary to its well-establi

152 those of other vitamin E analogs and the soy isoflavone genistein, a natural agonist of peroxisome pr

153 ufficient amounts of the predominant soybean isoflavone genistein.

154 The effects of resveratrol and the soy isoflavones genistein and daidzein on adipogenesis were

155 trated that dietary daidzein or combined soy isoflavones (genistein, daidzein, and glycitein) increas

156 We found that treatment with the isoflavone, genistein, from 28-52 hours postfertilizatio

157 degrees C, promoted efficient hydrolysis of isoflavone glicosides to their aglycon forms.

158 d isoflavone aglycons were increased but the isoflavones glucoside content decreased in the greenhous

159 nation of several classes of phytochemicals (isoflavones, glucosinolates, flavones, flavonols and phe

160 or a safe and efficient process to hydrolyse isoflavone glycosides in soy molasses.

161 o spent coffee grounds for the conversion of isoflavone glycosides into their aglycones in black soym

162 The significant bioconversion of the isoflavone glycosides into their corresponding bioactive

163 of the strains showed deglycosylation of the isoflavone glycosides present in soy drink and appearanc

164 s with formulations comprising predominantly isoflavone glycosides were included.Isoflavone treatment

165 dely used soy is a source of poorly absorbed isoflavones glycosides.

166 0.01 L (95% CI, -0.07 to 0.07 L) in the soy isoflavone group, which were not significantly different

167 owing interest in the health benefits of soy isoflavones has led to research in the isolation of indi

168 Isoflavones have an affinity for estrogen receptors (ERs

169 Soy isoflavones have antiestrogenic and anticancer propertie

170 Isoflavones have been associated with several health pro

171 The phytoestrogenic effects of isoflavones have led some to view soy foods and isoflavo

172 Soy isoflavones have variable effects on the prevention of p

173 Isoflavones, having chemical structures similar to estro

174 bust validated predictions were obtained for isoflavones, however less than robust calibrations were

175 lk significantly increased the conversion of isoflavone in ENTII (daidzein: 0.46 g/L; genistein: 0.18

176 fermented products capable of releasing high isoflavone in the digestive system.

177 d to determine the effects of the content of isoflavones in a soy supplement and the equol-producing

178 n of beta-glucosidase and convert glycosidic isoflavones in aglycones.

179 Genistin and Daidzin were the major isoflavones in all samples.

180 of beta-conglycinin (7S), glycinin (11S) and isoflavones in heated soymilk.

181 wn to the safety of using high levels of soy isoflavones in humans, which is especially the concern f

182 method allowed reliable determinations of 12 isoflavones in less than 8 min of chromatographic elutio

183 Although some recent studies have detected isoflavones in natural waters, little is known about the

184 lular senescence signaling by SPI-associated isoflavones in osteoblastic cells may explain the persis

185 In evaluation of thermal stability of isoflavones in soymilk at 97 degrees C for 25min, the da

186 s of their equol-producing status, and mixed isoflavones in their natural ratios are more effective t

187 was a significantly higher extractability of isoflavones in UHT (about 38%) than in UHPH-treated samp

188 ein-rich soy supplement and 3 doses of mixed isoflavones in various proportions) and a bisphosphonate

189 for constitutive accumulation of prenylated isoflavones in white lupin.

190 percentage of aglycone (total aglycone/total isoflavones) in SIM isoflavone extracts increased signif

191 attributed to high soy diets, and major soy isoflavones, in particular daidzein and genistein, are t

192 In addition, isoflavones including daidzein and genistein were also c

193 The content of aglycone isoflavones increased 2-fold, and the total phenolic con

194 Total isoflavones increased with the higher combination of pre

195 nderlying the SPI-protective effects involve isoflavone-induced normalization of insulin signaling in

196 Soy isoflavone intake (mg/d) was measured with validated foo

197 Despite large differences in soy isoflavone intake by country, isoflavone consumption was

198 a precise definition of the safety level of isoflavone intake requires additional studies.

199 , 0.71) for the highest categories of soy or isoflavone intake versus the lowest.

200 verse associations were observed for dietary isoflavone intake.

201 Isoflavones intake is associated with health benefits.

202 thy participants, short-term flavan-3-ol and isoflavone intakes improve vascular function; however, t

203 Phytoestrogen isoflavone intervention to engage the neuroprotective ef

204 The interconversion of isoflavones into beta-glucosides was faster in UHT than

205 A novel cytotoxic isoflavone is shown to inhibit heme oxygenase, a desirab

206 functional soy drink enriched with bioactive isoflavones is demonstrated in this work.

207 Daidzein, a soy isoflavone, is a clinically approved agent that has a ne

208 Biliatresone is an electrophilic isoflavone isolated from Dysphania species plants that h

209 e data suggest that supplementation with soy isoflavone may be an effective treatment for patients wi

210 However, soy isoflavones may also have a role in promoting breast can

211 ough selective estrogen receptor modulation, isoflavones may exert beneficial effects against estroge

212 The isoflavone metabolite equol was by far the predominant p

213 An isoflavone mixture similar to that found in serum of HF-

214 lavone supplement containing 100 mg of total isoflavones (n=193) or matching placebo (n=193) in 2 div

215 ty-six men were randomized to treatment with isoflavones (n=42) or placebo (n=44) for up to six weeks

216 s, anthocyanins, stilbenes, and the two main isoflavones of soybean, daidzein and genistein, in their

217 arameters and contents of different forms of isoflavones of the seeds and soybean sprouts were evalua

218 Effects of isoflavones on adipose tissue gene expression were influ

219 pression did not affect the actions of E2 or isoflavones on p53 expression in either ST2 or OB6 cells

220 We observe no impact of isoflavones on viability of healthy donor peripheral blo

221 gue, Czech Republic), containing 40% soybean isoflavones, on the contents of daidzein, glycitein, gen

222 ther stimulation of estrogenic signaling via isoflavones or through a novel and as yet uncharacterize

223 Interventions were 5 soy isoflavone oral supplements (2 doses of a genistein-rich

224 ily supplementation with 80 mg soy hypocotyl isoflavones over a 6-wk period had no effect on nitric o

225 contains only 18.07% of the original soybean isoflavones (p<0.001).

226 The pool enriched in chain prenylated isoflavones permeabilized the bacterial membrane within

227 he bioconversion and bioaccessibility of soy isoflavones produced in sogurt fermented with S. thermop

228 ain storage on the functional properties and isoflavone profile of soy protein concentrate.

229 The isoflavone profile showed a decrease in the concentratio

230 No differences in the isoflavone profile were found, with beta-glucoside conju

231 either heat nor UHPH treatments affected the isoflavone profile, as the percentage of each chemical f

232 Changes of isoflavone profile, protein digestibility and lysine ava

233 The probiotic viable cells, the isoflavones profile and organic acids were evaluated in

234 perature treatment altered phenolic acid and isoflavone profiles; however, total isoflavones were una

235 Changes of isoflavones, protein digestibility and lysine availabili

236 ng or simmering time-dependently reduces the isoflavone:protein ratio in Tofu.

237 king soy-juice for 15 or 60min decreases the isoflavone:protein ratios in Tofu from 6.90 to 3.57 and

238 re reduced by ultra-filtration (6.54 vs 1.24 isoflavone:protein; p<0.001).

239 Ara h 8 binds the isoflavones quercetin and apigenin as well as resveratro

240 In contrast, the evidence that isoflavones reduce bone loss in postmenopausal women is

241 Isoflavone reductase-like protein, S-adenosyl methionine

242 (rDau c 1.0104; rDau c 1.0201; rDau c 4; the isoflavone reductase-like proteins rDau c IFR 1, rDau c

243 A discussion on the changes in isoflavones related to temperature and time is reported.

244 Isoflavones, reported to have beneficial effects on huma

245 At 20 degrees C both isoflavones rose until the end of the experiment, reachi

246 ones (SPI) or 15 g soy protein alone without isoflavones (SP) daily for three months.

247 d to research in the isolation of individual isoflavone species for further application.

248 ed with 15 g soy protein containing 66 mg of isoflavones (SPI) or 15 g soy protein alone without isof

249 Isoflavones, such as genistein and daidzein, are metabol

250 ipants were randomly assigned to receive soy isoflavone supplement containing 100 mg of total isoflav

251 not significantly improve more with the soy isoflavone supplement than with placebo.

252 taking a controller medication, use of a soy isoflavone supplement, compared with placebo, did not re

253 d after control for pretreatment values, soy isoflavone supplementation had no effect on arginine flu

254 The objective was to test the effect of soy isoflavone supplementation on nitric oxide production an

255 LG isoflavone supplementation resulted in a caloric restric

256 The efficacy of soy isoflavone supplementation to stimulate nitric oxide pro

257 nd plasma lipid profile were not affected by isoflavone supplementation.

258 Isoflavone supplements also consistently alleviate menop

259 Soy isoflavone supplements are used to treat several chronic

260 flavones have led some to view soy foods and isoflavone supplements as alternatives to conventional h

261 ffects of an 8-wk consumption of 2 different isoflavone supplements compared with placebo on whole-ge

262 Isoflavone supplements, consumed by women experiencing m

263 nthesis was silenced via RNA interference of isoflavone synthase in soybean hairy root composite plan

264 Genistein is a soy isoflavone that has antitumor activity both in vitro and

265 atio of 20 to 1 and 20 degrees C, 47% of the isoflavones that can be extracted with 70% aqueous ethan

266 Soybeans are a rich source of isoflavones that have been linked with anti-inflammatory

267 parate the glucosidic and aglyconic forms of isoflavone, then individual species of isoflavone could

268 ystematic review and meta-analysis examining isoflavone therapies and bone mineral density (BMD) loss

269 ndomized controlled trials (RCTs) evaluating isoflavone therapies for treating BMD loss at the lumbar

270 was to optimise conversion of beta-glucoside isoflavones to aglycones in soymilk processing and to ev

271 The affinity of isoflavones to ERs was evaluated by molecular modelling

272 enhance chemical and enzymatic conversion of isoflavones to their aglycone forms.

273 -1)) were found in higher concentration than isoflavones (total content: 3.4-300.0 ug kg(-1)) and the

274 stein, glycetin, secoisolariciresinol, total isoflavones, total lignans, and total phytoestrogens wer

275 estradiol, PSA, and total cholesterol in the isoflavone-treated group compared to men receiving place

276 For the femoral neck (18 RCTs, n = 1604), isoflavone treatment showed a significantly (P < 0.01) h

277 At the lumbar spine, isoflavone treatment was associated with a significantly

278 The effect appears dependent on whether isoflavone treatments are in aglycone form; we conclude

279 minantly isoflavone glycosides were included.Isoflavone treatments exert a moderately beneficial effe

280 c acids, 5 flavones, 4 phenylethanoids and 1 isoflavone; V. polita: 10 flavones, 5 phenolic acids, 2

281 c acids, 2 phenylethanoids, 1 flavonol and 1 isoflavone; V. spuria: 10 phenolic acids, 5 flavones, 2

282 The content of isoflavones was determinate by ultra performance liquid

283 while no consistent increase of the four soy isoflavones was determined.

284 entions such as dietary and supplemental soy isoflavones were associated with improvement in daily ho

285 Flavonols and isoflavones were associated with seed coats and less tha

286 Isoflavones were converted into equol- or O-desmethylang

287 Estrogenic isoflavones were found, in the 1940s, to disrupt ewe rep

288 Furthermore, isoflavones were highly associated with seed maturity on

289 ralolide and flavonoids such as flavones and isoflavones were identified.

290 oratory and animal studies reported that soy isoflavones were major bioactive compounds in soy to exe

291 sis, cell cycles and cellular uptakes of the isoflavones were measured after 48 h.

292 Saponins, flavonols and isoflavones were quantified in sprouts, cotyledons and s

293 Soy-juice isoflavones were reduced by ultra-filtration (6.54 vs 1.

294 acid and isoflavone profiles; however, total isoflavones were unaffected.

295 ery (82-97%) and purity (92-95%) of the four isoflavones, which confirms a high separating efficiency

296 ME-344 is a second-generation isoflavone with unusual cytotoxic properties that is in

297 ermentation was more efficient in converting isoflavones with M. purpureus NRRL 1992.

298 Bioavailable isoflavones with selective estrogen receptor affinity sh

299 g increase in the concentrations of aglycone isoflavones, with the magnitude of these changes increas

300 ction with 65% aqueous methanol gave a total isoflavone yield of 345 mg/100 g soybean, the highest va